Comparison

RABBIT ANTI CASPASE-7 (N-TERMINAL)

Item no. 18-783-313894
Manufacturer GENWAY
Amount 0.05 mg
Category
Type Antibody
Applications WB
Specific against other
Host Rabbit
ECLASS 10.1 32160702
ECLASS 11.0 32160702
UNSPSC 12352203
Alias GWB-DCD658
Similar products 18-783-313894
Available
Genway ID:
GWB-DCD658
Specificity:
CASPASE-7 (N-TERMINAL)
Isotype:
Polyclonal IgGSpecies Cross Reactivity: Reacts with: Mouse RatN. B. Antibody reactivity and working conditions may vary between species.
Buffer Solution:
Phosphate buffered saline
Preservative Stabilisers:
0. 02% Sodium Azide (NaN3)Approx. Protein Concentrations: IgG concentration 1. 0mg/ml
Immunogen:
A 16 amino acid peptide from human Caspase-7 amino-terminus
Specificity:
Recognises an epitope within the N-terminal region (NT) of Caspase-7 a 35kDa cysteine protease otherwise known as ICE-like Apoptotic Protease 3 (ICE-LAP3). Caspase-7 a member of the ICE/Ced-3 subfamily is an executioner caspase which undergoes proteolytic cleavage of its precursor to form active p12 and p20 subunits. Evidence that activation of Caspase-7 occurs during cell death induced by the cytokine death receptors Fas/APO-1 and the receptor of tumour necrosis factor (TNFR-1) coupled with the fact that granzyme-B activated Caspase-7 cleaves the nuclear enzyme poly (ADP-ribose) polymerase (PARP) suggests an important role for Caspase-7 in both cytokine-mediated and Granzyme-B mediated apoptosis pathways. Recommended Secondary Antibodies: Sheep Anti Rabbit IgGGoat Anti Rabbit IgG (Fc)Goat Anti Rabbit IgG (H/L)
Function:
Involved in the activation cascade of caspases responsible for apoptosis execution. Cleaves and activates sterol regulatory element binding proteins (SREBPs). Proteolytically cleaves poly(ADP-ribose) polymerase (PARP) at a \' 216-Asp-|-Gly-217\' bond. Overexpression promotes programmed cell death. Catalytic activityStrict requirement for an Asp residue at position P1 and has a preferred cleavage sequence of Asp-Glu-Val-Asp-|-. Enzyme regulationInhibited by isatin sulfonamides. Subunit structureHeterotetramer that consists of two anti-parallel arranged heterodimers each one formed by a 20 kDa (p20) and a 11 kDa (p11) subunit. Ref. 13Subcellular locationCytoplasm. Tissue specificityHighly expressed in lung skeletal muscle liver kidney spleen and heart and moderately in testis. No expression in the brain. Post-translational modificationCleavages by granzyme B or caspase-10 generate the two active subunits. Propeptide domains can also be cleaved efficiently by caspase-3. Active heterodimers between the small subunit of caspase-7 and the large subunit of caspase-3 and vice versa also occur. Ref. 10Sequence similaritiesBelongs to the peptidase C14A family. 1. Cao Z. et al. (2001) Interferon-inducible protein 10 induction and inhibition of angiogenesis in vivo by the antitumor agent 5 6-Dimethylxanthenone-4-acetic acid (DMXAA). Cancer Res. 61: 1517 - 1521. [1] \" Isolation and bacterial expression of a murine alpha leukocyte interferon gene. \" Daugherty B. Martin-Zanca D. Kelder B. Collier K. Seamans T. C. Hotta K. Pestka S. J. Interferon Res. 4:635-643(1984) [PubMed: 6094686] [Abstract]Cited for: NUCLEOTIDE SEQUENCE. [2] \" A comparison of whole-genome shotgun-derived mouse chromosome 16 and the human genome. \" Mural R. J. Adams M. D. Myers E. W. Smith H. O. Miklos G. L. Wides R. Halpern A. Li P. W. Sutton G. G. Nadeau J. Salzberg S. L. Holt R. A. Kodira C. D. Lu F. Chen L. Deng Z. Evangelista C. C. Gan W. Heiman T. J. Li J. Li Z. Merkulov G. V. Milshina N. V. Naik A. K. Qi R. Shue B. C. Wang A. Wang J. Wang X. Yan X. Ye J. Yooseph S. Zhao Q. Zheng L. Zhu S. C. Biddick K. Bolanos R. Delcher A. L. Dew I. M. Fasulo D. Flanigan M. J. Huson D. H. Kravitz S. A. Miller J. R. Mobarry C. M. Reinert K. Remington K. A. Zhang Q. Zheng X. H. Nusskern D. R. Lai Z. Lei Y. Zhong W. Yao A. Guan P. Ji R. R. Gu Z. Wang Z. Y. Zhong F. Xiao C. Chiang C. C. Yandell M. Wortman J. R. Amanatides P. G. Hladun S. L. Pratts E. C. Johnson J. E. Dodson K. L. Woodford K. J. Evans C. A. Gropman B. Rusch D. B. Venter E. Wang M. Smith T. J. Houck J. T. Tompkins D. E. Haynes C. Jacob D. Chin S. H. Allen D. R. Dahlke C. E. Sanders R. Li K. Liu X. Levitsky A. A. Majoros W. H. Chen Q. Xia A. C. Lopez J. R. Donnelly M. T. Newman M. H. Glodek A. Kraft C. L. Nodell M. Ali F. An H. J. Baldwin-Pitts D. Beeson K. Y. Cai S. Carnes M. Carver A. Caulk P. M. Center A. Chen Y. H. Cheng M. L. Coyne M. D. Crowder M. Danaher S. Davenport L. B. Desilets R. Dietz S. M. Doup L. Dullaghan P. Ferriera S. Fosler C. R. Gire H. C. Gluecksmann A. Gocayne J. D. Gray J. Hart B. Haynes J. Hoover J. Howland T. Ibegwam C. Jalali M. Johns D. Kline L. Ma D. S. MacCawley S. Magoon A. Mann F. May D. McIntosh T. C. Mehta S. Moy L. Moy M. C. Murphy B. J. Murphy S. D. Nelson K. A. Nuri Z. Parker K. A. Prudhomme A. C. Puri V. N. Qureshi H. Raley J. C. Reardon M. S. Regier M. A. Rogers Y. H. Romblad D. L. Schutz J. Scott J. L. Scott R. Sitter C. D. Smallwood M. Sprague A. C. Stewart E. Strong R. V. Suh E. Sylvester K. Thomas R. Tint N. N. Tsonis C. Wang G. Wang G. Williams M. S. Williams S. M. Windsor S. M. Wolfe K. Wu M. M. Zaveri J. Chaturvedi K. Gabrielian A. E. Ke Z. Sun J. Subramanian G. Venter J. C. Pfannkoch C. M. Barnstead M. Stephenson L. D. Science 296:1661-1671(2002) [PubMed: 12040188] [Abstract]Cited for: NUCLEOTIDE SEQUENCE. Strain: Mixed EMBL EDL30976. 1. [3] Mural R. J. Adams M. D. Myers E. W. Smith H. O. Venter J. C. Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE. Strain: Mixed EMBL EDL30976. 1. [4] Tracey A. Submitted (JAN-2009) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE. [5] \" The status quality and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC). \" The MGC Project TeamGenome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: PCR rescued clones EMBL AAI16217. 1.

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Amount: 0.05 mg
Available: In stock
available

Compare

Add to wishlist

Get an offer

Request delivery time

Ask a technical question

Submit a bulk request

Questions about this Product?
 
Close